This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by CHYUN, Y. S. Articles by RAISZ, L. G. Search for Related Content PubMed PubMed Citation Articles by CHYUN, Y. S. Articles by RAISZ, L. G.

Cortisol Decreases Bone Formation by Inhibiting Periosteal Cell Proliferation^*

Division of Endocrinology and Metabolism, University of Connecticut Health Center Farmington, Connecticut 06032

Address requests for reprints to: Dr. Yong S. Chyun, Department of Medicine, University of Connecticut Health Center, Farmington, Connecticut 06032.

Abstract

We tested the hypothesis that the inhibitory effect of cortisol on bone growth is primarily on the periosteum. Fetal rat calvaria were maintained in organ culture, labeled with radioactive proline or thymidine, and then dissected to separate periosteum from the osteoblast-rich central bone. There was a dose- and time-dependent inhibition of thymidine incorporation into DNA in the periosteum which was significant at 24 h. These observations were further supported by decreases in the dry weight and DNA content of the periosteum at 96 h. Incorporation of thymidine and proline into the central bone were decreased only at 96 h. Pulse-chase studies using a high concentration of cortisol (10^–6 M) indicated that increased cell attrition may also play a role in the inhibitory effect of cortisol. We propose that the primary effect of cortisol on bone growth is an inhibition of proliferation of the periosteal cells which give rise to osteoblasts. The subsequent decrease in the incorporation of proline into the central bone may be the consequence of this inhibition. (Endocrinology 114: 477, 1984)

Footnotes

^* This work was supported in part by Grants AM-18063 and AM-07290 from the NIH and a grant from the Kroc Foundation.

Received December 8, 1982.

This article has been cited by other articles:

				A. Takuma, T. Kaneda, T. Sato, S. Ninomiya, M. Kumegawa, and Y. Hakeda Dexamethasone Enhances Osteoclast Formation Synergistically with Transforming Growth Factor-{beta} by Stimulating the Priming of Osteoclast Progenitors for Differentiation into Osteoclasts J. Biol. Chem., November 7, 2003; 278(45): 44667 - 44674. [Abstract] [Full Text] [PDF]

				B. P. Lukert and L. G. Raisz Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management Ann Intern Med, March 1, 1990; 112(5): 352 - 364. [Abstract] [PDF]